Brigida Barberio (@bribarberio) 's Twitter Profile
Brigida Barberio

@bribarberio

Gastroenterologist (MD, PhD) University of Padova, Italy. UEG Quality of Care Committee Member. ECCO EpiCom Committee Member. ECCO News Associate Editor

ID: 558945895

calendar_today20-04-2012 21:07:55

243 Tweet

305 Followers

297 Following

ignacio catalan (@ign76) 's Twitter Profile Photo

🔵 New issue of ECCO News is out!!! ✍🏼Closing 2023 with lots of exciting news in IBD: Global IBD, Nat reps, ECCO24, Y-ECCO, JCC podcast and more… Take a 👀👇🏻 We hope you like it and we wish you all Merry Christmas from the editorial team! 💫🎄 ecco-ibd.eu/publications/e…

🔵 New issue of ECCO News is out!!!

✍🏼Closing 2023 with lots of exciting news in IBD: Global IBD, Nat reps, ECCO24, <a href="/Y_ECCO_IBD/">Y-ECCO</a>, JCC podcast and more… Take a 👀👇🏻

We hope you like it and we wish you all Merry Christmas from the editorial team! 💫🎄

ecco-ibd.eu/publications/e…
Brigida Barberio (@bribarberio) 's Twitter Profile Photo

🥁Hi all, the Spring Issue of the ECCO News is out!!! Enjoy our articles and podcast! Here, you can find my article with an overview of ECCO 2024 Scientific and Educational Programmes. 👉🏻ecco-ibd.eu/publications/e…

🥁Hi all, the Spring Issue of the ECCO News is out!!!
Enjoy our articles and podcast! 

Here, you can find my article with an overview of ECCO 2024 Scientific and Educational Programmes.

👉🏻ecco-ibd.eu/publications/e…
Piotr Eder (@ederpiotr) 's Twitter Profile Photo

A 1-year follow-up study on checkpoint inhibitor-induced colitis sciencedirect.com/science/articl… ESMO - Eur. Oncology 👉ICI-induced colitis: different patterns and prognosis 👈 Prof. Lenti & prof. Di Sabatino - 🙏for being involved 🙏to Davide G. Ribaldone alessandro armuzzi and ALL co-authors

A 1-year follow-up study on checkpoint inhibitor-induced colitis

sciencedirect.com/science/articl… 

<a href="/myESMO/">ESMO - Eur. Oncology</a> 

👉ICI-induced colitis: different patterns and prognosis 👈

Prof. Lenti &amp; prof. Di Sabatino - 🙏for being involved

🙏to <a href="/physician1983/">Davide G. Ribaldone</a> <a href="/alearmuzzi/">alessandro armuzzi</a> and ALL co-authors
Pierfrancesco Visaggi, MD (@pierfra_visaggi) 's Twitter Profile Photo

Our paper on #ArtificialInteligence in #Esophageal #Diseases is still one of the #TOP #Downloaded 🤩🤩🤩 Maybe you haven't had a read yet? It's #OpenAccess ⬇️⬇️⬇️ ncbi.nlm.nih.gov/pmc/articles/P… Brigida Barberio Edoardo Savarino

Our paper on #ArtificialInteligence in #Esophageal #Diseases is still one of the #TOP #Downloaded 🤩🤩🤩
Maybe you haven't had a read yet?
It's #OpenAccess 
⬇️⬇️⬇️
ncbi.nlm.nih.gov/pmc/articles/P…

<a href="/bribarberio/">Brigida Barberio</a> <a href="/EdoardoSavarino/">Edoardo Savarino</a>
Brigida Barberio (@bribarberio) 's Twitter Profile Photo

Patients with IBD may experience symptoms of sexual dysfunction (SD). However, the magnitude of this problem remains uncertain. Here, is our latest meta-analysis on the global prevalence of SD in IBD Olga Maria Nardone Giulio Calabrese Alexander Ford --> pubmed.ncbi.nlm.nih.gov/39185800/

Brigida Barberio (@bribarberio) 's Twitter Profile Photo

Proud to contribute to the Quality of Care Committee and collaborate with such an inspiring group! Advancing excellence in digestive health, one step at a time. #myUEGcommunity #weareUEG

Brigida Barberio (@bribarberio) 's Twitter Profile Photo

The pleasure was all mine! I truly appreciate your kind words and admire your work as well. Looking forward to meeting you again! my_UEG

Brigida Barberio (@bribarberio) 's Twitter Profile Photo

✨ ECCO Congress has just begun, and so has my new journey as an EpiCom Committee Member! ✨ I am truly grateful and excited to start this new adventure, working alongside an incredible team. 💡🔬 #ECCO2025 #EpiCom #GreatTeamwork #NewBeginnings

✨ ECCO Congress has just begun, and so has my new journey as an EpiCom Committee Member! ✨ 
I am truly grateful and excited to start this new adventure, working alongside an incredible team.
💡🔬 #ECCO2025 #EpiCom #GreatTeamwork #NewBeginnings
Seb (@ibdseb) 's Twitter Profile Photo

Gil Kaplan MD MPH #ECCO2025 Brilliant and clear lecturer IBD epidemiology modelling to highlight WHAT is coming our way and WHEN in global #IBD 🤔potential avenues to meet global 🌎#IBD challenges

<a href="/gilkaplan/">Gil Kaplan MD MPH</a> #ECCO2025
Brilliant and clear lecturer 

IBD epidemiology modelling  to highlight WHAT is coming our way and WHEN   in global #IBD 

🤔potential avenues to meet global  🌎#IBD challenges
Brigida Barberio (@bribarberio) 's Twitter Profile Photo

I am thrilled to share that I have officially completed my Master's degree in Nutrition!🌟🎓 As part of this journey, I dedicated my thesis to a topic that I am deeply passionate about: "Dietary Strategies and Oral Nutritional Supplementation in IBD."

I am thrilled to share that I have officially completed my Master's degree in Nutrition!🌟🎓
As part of this journey, I dedicated my thesis to a topic that I am deeply passionate about: "Dietary Strategies and Oral Nutritional Supplementation in IBD."
Brigida Barberio (@bribarberio) 's Twitter Profile Photo

📢 Just published our latest paper examining the relative efficacy of biologics and small molecules in maintaining remission in UC by network meta-analysis according to trial design. Huge thanks to Alexander Ford for the mentorship! pubmed.ncbi.nlm.nih.gov/40407729/

📢 Just published our latest paper examining the relative efficacy of biologics and small molecules in maintaining remission in UC by network meta-analysis according to trial design. Huge thanks to <a href="/alex_ford12399/">Alexander Ford</a> for the mentorship! 

pubmed.ncbi.nlm.nih.gov/40407729/
Beatriz Gros (@bealoquebea) 's Twitter Profile Photo

In a UK study of 5.16M pregnancies (2000–2021), autoimmune disease in pregnancy rose from 3.5% to 4.7%. IBD was the 2nd most prevalent autoimmune condition after psoriasis. Autoimmune risk was higher in ex-smokers, multiparas, and women with mental or metabolic comorbidities.

In a UK study of 5.16M pregnancies (2000–2021), autoimmune disease in pregnancy rose from 3.5% to 4.7%. IBD was the 2nd most prevalent autoimmune condition after psoriasis. 

Autoimmune risk was higher in ex-smokers, multiparas, and women with mental or metabolic comorbidities.